Mgr. Hana Plešingerová, Ph.D.
Researcher II, Section of Animal Physiology and Immunology
office: bldg. D36/1S14
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 6097 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 33
2018
-
Promoter methylation of ROR1 ligand WNT5A associates with its expression in CLL
Year: 2018, type: Conference abstract
2017
-
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status
LEUKEMIA & LYMPHOMA, year: 2017, volume: 58, edition: 1, DOI
-
Promoter methylation of ROR ligand WNTA associates with its expression in chronic lymphocytic leukemia
Year: 2017, type: Conference abstract
2016
-
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Clinical cancer research, year: 2016, volume: 22, edition: 2, DOI
-
Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV
Year: 2016, type: Conference abstract
-
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV
British journal of haematology, year: 2016, volume: 175, edition: 5, DOI
2015
-
13Q deletion in predominant cytogenetic aberration newly aquired during chronic lymohocytic leukemia course irrespective of disease activity and treatment status.
Year: 2015, type: Conference abstract
-
COBLL1 as a survival predictor in chronic lymphocytic leukaemia patients.
Year: 2015, type: Conference abstract
-
Sada pro stanovení prognózy chronické lymfocytární leukémie
Year: 2015
-
Upregulated COBLL1 in chronic lymphocytic leukaemia (CLL) patients with unmutated IGHV identifies a cohort with inferior prognosis
Year: 2015, type: Conference abstract